| UV activation of polymeric high aspect ratio microstructures: ramifications in antibody surface loading for circulating tumor cell selection JM Jackson, MA Witek, ML Hupert, C Brady, S Pullagurla, J Kamande, ... Lab on a Chip 14 (1), 106-117, 2014 | 88 | 2014 |
| Surface charge, electroosmotic flow and DNA extension in chemically modified thermoplastic nanoslits and nanochannels FI Uba, SR Pullagurla, N Sirasunthorn, J Wu, S Park, R Chantiwas, ... Analyst 140 (1), 113-126, 2015 | 80 | 2015 |
| Simple replication methods for producing nanoslits in thermoplastics and the transport dynamics of double-stranded DNA through these slits R Chantiwas, ML Hupert, SR Pullagurla, S Balamurugan, J Tamarit-López, ... Lab on a Chip 10 (23), 3255-3264, 2010 | 72 | 2010 |
| Characterization of activated cyclic olefin copolymer: effects of ethylene/norbornene content on the physiochemical properties CE O'Neil, S Taylor, K Ratnayake, S Pullagurla, V Singh, SA Soper Analyst 141 (24), 6521-6532, 2016 | 37 | 2016 |
| Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion molecule MA Witek, RD Aufforth, H Wang, JW Kamande, JM Jackson, ... NPJ precision oncology 1 (1), 24, 2017 | 34 | 2017 |
| Parallel affinity-based isolation of leukocyte subsets using microfluidics: application for stroke diagnosis SR Pullagurla, MA Witek, JM Jackson, MAM Lindell, ML Hupert, ... Analytical chemistry 86 (8), 4058-4065, 2014 | 33 | 2014 |
| Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the NanopatchTM Microneedle … Y Wan, V Gupta, C Bird, SR Pullagurla, P Fahey, A Forster, DB Volkin, ... Human vaccines & immunotherapeutics 17 (8), 2501-2516, 2021 | 13 | 2021 |
| Current and future bioanalytical approaches for stroke assessment SR Pullagurla, AE Baird, MG Adamski, SA Soper Bioanalysis 7 (8), 1017-1035, 2015 | 12 | 2015 |
| Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low-and middle-income countries P Kumar, RS Shukla, A Patel, SR Pullagurla, C Bird, O Ogun, OS Kumru, ... Human Vaccines & Immunotherapeutics 17 (7), 2298-2310, 2021 | 10 | 2021 |
| Effect of formulation variables on the stability of a live, rotavirus (RV3-BB) vaccine candidate using in vitro Gastric Digestion models to mimic oral delivery P Kumar, SR Pullagurla, A Patel, RS Shukla, C Bird, OS Kumru, A Hamidi, ... Journal of Pharmaceutical Sciences 110 (2), 760-770, 2021 | 9 | 2021 |
| Recent and near-future advances in nucleic acid-based diagnosis of stroke AE Baird, SA Soper, SR Pullagurla, MG Adamski Expert review of molecular diagnostics 15 (5), 665-679, 2015 | 9 | 2015 |
| Analytical and preformulation characterization studies of human papillomavirus virus-like particles to enable quadrivalent multi-dose vaccine formulation development K Jerajani, Y Wan, JM Hickey, OS Kumru, N Sharma, SR Pullagurla, ... Journal of Pharmaceutical Sciences 111 (11), 2983-2997, 2022 | 6 | 2022 |
| Modeling the long-term 2-8 C stability profiles of a live, rotavirus vaccine candidate (RV3-BB) in various liquid formulations via extrapolations of real-time and accelerated … SR Pullagurla, P Kumar, O Ogun, OS Kumru, A Hamidi, F Hoeksema, ... Biologicals 75, 21-28, 2022 | 6 | 2022 |
| Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine A Hamidi, F Hoeksema, P Velthof, A Lemckert, G Gillissen, A Luitjens, ... Vaccine 39 (15), 2048-2059, 2021 | 5 | 2021 |
| Multi-dose formulation development for a quadrivalent human papillomavirus virus-like particle-based vaccine: part II-Real-time and accelerated stability studies N Sharma, K Jerajani, Y Wan, OS Kumru, SR Pullagurla, O Ogun, ... Journal of Pharmaceutical Sciences 112 (2), 458-470, 2023 | 3 | 2023 |
| Multi-dose formulation development for a quadrivalent human papillomavirus virus-like particle-based vaccine: part I-screening of preservative combinations K Jerajani, Y Wan, OS Kumru, SR Pullagurla, P Kumar, N Sharma, ... Journal of Pharmaceutical Sciences 112 (2), 446-457, 2023 | 3 | 2023 |
| Formulation development of a stable, orally delivered live human neonatal rotavirus (rv3-bb) vaccine candidate P Kumar, S Pullagurla, RS Shukla, A Patel, C Bird, O Kumru, SB Joshi, ... | | 2018 |
| Formulation development of a stable, orally delivered live human neonatal rotavirus (rv3-bb) vaccine candidate DBV Prashant Kumar, Swathi Pullagurla, Ravi S Shukla, Ashaben Patel ... VACCINE TECHNOLOGY VII, 2018 | | 2018 |
| Elucidating transport dynamics of single molecules in thermoplastic nanochanels YK Cho, C O'Neil, F Uba, S Pullagurla, K Ratnayake, SH Shim, SA Soper Chemical and Biological Microsystems Society, 2014 | | 2014 |
| Polymer Micro-and Nanofluidic Systems for In Vitro Diagnostics: Analyzing Single Cells and Molecules SR Pullagurla Louisiana State University and Agricultural & Mechanical College, 2014 | | 2014 |
Steven SoperProfessor Chemistry and Mechanical Engineering, The University of KansasDirección de correo verificada de ku.edu
